Literature DB >> 12093668

Evidence for the presence of immune dysfunction in chronic fatigue syndrome.

Benjamin H Natelson1, Mohammad H Haghighi, Nicholas M Ponzio.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12093668      PMCID： PMC120010          DOI： 10.1128/cdli.9.4.747-752.2002

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN： 1071-412X


× No keyword cloud information.
  67 in total

1.  TNF-alpha and chronic fatigue syndrome.

Authors:  R B Moss; A Mercandetti; A Vojdani
Journal:  J Clin Immunol       Date:  1999-09       Impact factor: 8.317

2.  Acute phase responses and cytokine secretion in chronic fatigue syndrome.

Authors:  J G Cannon; J B Angel; R W Ball; L W Abad; L Fagioli; A L Komaroff
Journal:  J Clin Immunol       Date:  1999-11       Impact factor: 8.317

3.  Immune responses associated with chronic fatigue syndrome: a case-control study.

Authors:  A C Mawle; R Nisenbaum; J G Dobbins; H E Gary; J A Stewart; M Reyes; L Steele; D S Schmid; W C Reeves
Journal:  J Infect Dis       Date:  1997-01       Impact factor: 5.226

4.  Influence of immediate hypersensitivity skin reactions on delayed reactions in patients with chronic fatigue syndrome.

Authors:  P Steinberg; A Pheley; P K Peterson
Journal:  J Allergy Clin Immunol       Date:  1996-12       Impact factor: 10.793

5.  Clinical and immunologic study of 205 patients with chronic fatigue syndrome: a case series from Italy.

Authors:  V Tirelli; A Pinto; G Marotta; M Crovato; M Quaia; P De Paoli; E Galligioni; G Santini
Journal:  Arch Intern Med       Date:  1993-01-11

6.  Disturbed neuroendocrine-immune interactions in chronic fatigue syndrome.

Authors:  A Kavelaars; W Kuis; L Knook; G Sinnema; C J Heijnen
Journal:  J Clin Endocrinol Metab       Date:  2000-02       Impact factor: 5.958

7.  Immunoglobulin subclass levels in chronic fatigue syndrome.

Authors:  A L Bennett; L R Fagioli; P H Schur; R S Schacterle; A L Komaroff
Journal:  J Clin Immunol       Date:  1996-11       Impact factor: 8.317

8.  Depression and reduced natural killer cytotoxicity: a longitudinal study of depressed patients and control subjects.

Authors:  M Irwin; U Lacher; C Caldwell
Journal:  Psychol Med       Date:  1992-11       Impact factor: 7.723

9.  Serum levels of lymphokines and soluble cellular receptors in primary Epstein-Barr virus infection and in patients with chronic fatigue syndrome.

Authors:  A Linde; B Andersson; S B Svenson; H Ahrne; M Carlsson; P Forsberg; H Hugo; A Karstorp; R Lenkei; A Lindwall
Journal:  J Infect Dis       Date:  1992-06       Impact factor: 5.226

10.  Increased production of interleukin-6 by adherent and non-adherent mononuclear cells during 'natural fatigue' but not following 'experimental fatigue' in patients with chronic fatigue syndrome.

Authors:  S Gupta; S Aggarwal; A Starr
Journal:  Int J Mol Med       Date:  1999-02       Impact factor: 4.101
View more
  29 in total

1.  Cytokine responses to exercise and activity in patients with chronic fatigue syndrome: case-control study.

Authors:  L V Clark; M Buckland; G Murphy; N Taylor; V Vleck; C Mein; E Wozniak; M Smuk; P D White
Journal:  Clin Exp Immunol       Date:  2017-10-11       Impact factor: 4.330

2.  Cytokines across the night in chronic fatigue syndrome with and without fibromyalgia.

Authors:  Toru Nakamura; Stephan K Schwander; Robert Donnelly; Felix Ortega; Fumiharu Togo; Gordon Broderick; Yoshiharu Yamamoto; Neil S Cherniack; David Rapoport; Benjamin H Natelson
Journal:  Clin Vaccine Immunol       Date:  2010-02-24

3.  A nanoelectronics-blood-based diagnostic biomarker for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).

Authors:  R Esfandyarpour; A Kashi; M Nemat-Gorgani; J Wilhelmy; R W Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-29       Impact factor: 11.205

4.  Elevated Energy Production in Chronic Fatigue Syndrome Patients.

Authors:  Nick Lawson; Chung-Han Hsieh; Dana March; Xinnan Wang
Journal:  J Nat Sci       Date:  2016

5.  Evidence for T-helper 2 shift and association with illness parameters in chronic fatigue syndrome (CFS).

Authors:  Susan Torres-Harding; Matthew Sorenson; Leonard A Jason; Kevin Maher; Mary Ann Fletcher
Journal:  Bull IACFS ME       Date:  2008

6.  Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case series.

Authors:  Øystein Fluge; Olav Mella
Journal:  BMC Neurol       Date:  2009-07-01       Impact factor: 2.474

7.  Gut inflammation in chronic fatigue syndrome.

Authors:  Shaheen E Lakhan; Annette Kirchgessner
Journal:  Nutr Metab (Lond)       Date:  2010-10-12       Impact factor: 4.169

Review 8.  Mycoplasma blood infection in chronic fatigue and fibromyalgia syndromes.

Authors:  Gerhard K M Endresen
Journal:  Rheumatol Int       Date:  2003-07-16       Impact factor: 2.631

9.  Moderate exercise increases expression for sensory, adrenergic, and immune genes in chronic fatigue syndrome patients but not in normal subjects.

Authors:  Alan R Light; Andrea T White; Ronald W Hughen; Kathleen C Light
Journal:  J Pain       Date:  2009-07-31       Impact factor: 5.820

10.  Extended B cell phenotype in patients with myalgic encephalomyelitis/chronic fatigue syndrome: a cross-sectional study.

Authors:  F Mensah; A Bansal; S Berkovitz; A Sharma; V Reddy; M J Leandro; G Cambridge
Journal:  Clin Exp Immunol       Date:  2016-02-22       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.